Showing results (1511-1520 of 1,613) with videos related to

Sort By:
Pageof 162
JAMA Oncology|March 5, 2026
Outcomes of Older Adults With Advanced Cancer Who Prefer Quality of Life vs Prolonging Survival: A Secondary Analysis of the GAP70+ Cluster Randomized Clinical TrialDaniel R Richardson, Ying Wang, Marie Flannery, et al.
JAMA Oncology|July 7, 2022
Global Association of COVID-19 Pandemic Measures With Cancer Screening: A Systematic Review and Meta-analysisFederica Teglia, Marco Angelini, Laura Astolfi, et al.
JAMA Oncology|October 28, 2016
Prognostic Survival Associated With Left-Sided vs Right-Sided Colon Cancer: A Systematic Review and Meta-analysisFausto Petrelli, Gianluca Tomasello, Karen Borgonovo, et al.
JAMA Oncology|November 11, 2016
Evaluation of the Feasibility of Screening Patients for Early Signs of Lung Carcinoma in Web Search LogsRyen W White, Eric Horvitz
JAMA Oncology|November 11, 2016
Vaginal Testosterone Cream vs Estradiol Vaginal Ring for Vaginal Dryness or Decreased Libido in Women Receiving Aromatase Inhibitors for Early-Stage Breast Cancer: A Randomized Clinical TrialMichelle E Melisko, Mindy E Goldman, Jimmy Hwang, et al.
JAMA Oncology|January 6, 2017
Comparison of Survival Outcomes Among Human Papillomavirus-Negative cT1-2 N1-2b Patients With Oropharyngeal Squamous Cell Cancer Treated With Upfront Surgery vs Definitive Chemoradiation Therapy: An Observational StudyJacqueline R Kelly, Henry S Park, Yi An, et al.
JAMA Oncology|December 23, 2016
Association of DNA Mismatch Repair and Mutations in BRAF and KRAS With Survival After Recurrence in Stage III Colon Cancers : A Secondary Analysis of 2 Randomized Clinical TrialsFrank A Sinicrope, Qian Shi, Carmen J Allegra, et al.
JAMA Oncology|November 12, 2020
Clinical Characteristics, Experiences, and Outcomes of Transgender Patients With CancerZackory T Burns, Danielle S Bitterman, Subha Perni, et al.
JAMA Oncology|November 5, 2016
Association of Polymorphisms in FCGR2A and FCGR3A With Degree of Trastuzumab Benefit in the Adjuvant Treatment of ERBB2/HER2-Positive Breast Cancer: Analysis of the NSABP B-31 TrialPatrick G Gavin, Nan Song, S Rim Kim, et al.
JAMA Oncology|December 6, 2016
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study, Christina Fitzmaurice, Christine Allen, et al.
Pageof 162